Shock resident survival guide: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#FIRE: Focused Initial Rapid Evaluation|FIRE]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#FIRE: Focused Initial Rapid Evaluation|FIRE]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Approach|Approach]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Treatment|Treatment]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Do's|Do's]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC; border-radius: 5px 5px 5px 5px;" align=left | [[{{PAGENAME}}#Do's|Do's]]
Line 94: Line 94:




==Approach==
<span style="font-size: 75%">
{{Family tree/start}}
{{Family tree/start}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; width: 220px; height: 140px;| | | | | | | | | | | | | B01 | | | | | | | | | | | | | |B01=
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left; width: 220px; height: 140px; | | | | | | | | | | | | | B01 | | | | | | | | | | | | | |B01=
<center>'''Symptoms & Signs'''</center><br>
<center>'''Symptoms & Signs'''</center><br>
----
----
Line 105: Line 103:
❑ Oliguria (urine output <0.5 mL/kg/h)<br>
❑ Oliguria (urine output <0.5 mL/kg/h)<br>
❑ Tachycardia (heart rate >100 bpm)}}
❑ Tachycardia (heart rate >100 bpm)}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left; height: 20px;              | | | | | | | | | | | | | B02 | | | | | | | | | | | | | |B02=
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left; height: 20px;              | | | | | | | | | | | | | B02 | | | | | | | | | | | | | |B02=
<center>'''Shock'''</center>}}
<center>'''Shock'''</center>}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 100px;              | | | | | | | | | | | | | B03 | | | | | | | | | | | | | |B03=
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 20px; padding: 5px; text-align: left; height: 100px;              | | | | | | | | | | | | | B03 | | | | | | | | | | | | | |B03=
<center>'''Ventilate—Infuse—Pump (VIP)'''<ref name="Weil-1969">{{Cite journal  | last1 = Weil | first1 = MH. | last2 = Shubin | first2 = H. | title = The VIP approach to the bedside management of shock. | journal = JAMA | volume = 207 | issue = 2 | pages = 337-40 | month = Jan | year = 1969 | doi =  | PMID = 5818156 }}</ref><ref name="Vincent-2013">{{Cite journal | last1 = Vincent | first1 = JL. | last2 = De Backer | first2 = D. | title = Circulatory shock. | journal = N Engl J Med | volume = 369 | issue = 18 | pages = 1726-34 | month = Oct | year = 2013 | doi = 10.1056/NEJMra1208943 | PMID = 24171518 }}</ref></center>
<center>'''Ventilate—Infuse—Pump (VIP)'''<ref name="Weil-1969">{{Cite journal  | last1 = Weil | first1 = MH. | last2 = Shubin | first2 = H. | title = The VIP approach to the bedside management of shock. | journal = JAMA | volume = 207 | issue = 2 | pages = 337-40 | month = Jan | year = 1969 | doi =  | PMID = 5818156 }}</ref><ref name="Vincent-2013">{{Cite journal | last1 = Vincent | first1 = JL. | last2 = De Backer | first2 = D. | title = Circulatory shock. | journal = N Engl J Med | volume = 369 | issue = 18 | pages = 1726-34 | month = Oct | year = 2013 | doi = 10.1056/NEJMra1208943 | PMID = 24171518 }}</ref></center>
----
----
Line 115: Line 113:
❑ Normal saline 0.5–1 L q10–15 min<sup>†</sup><br>
❑ Normal saline 0.5–1 L q10–15 min<sup>†</sup><br>
❑ Norepinephrine 0.1–2.0 μg/kg/min}}
❑ Norepinephrine 0.1–2.0 μg/kg/min}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 200px;              | | | | | | | | | | | | | B04 | | | | | | | | | | | | | |B04=
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 20px; padding: 5px; text-align: left; height: 180px;              | | | | | | | | | | | | | B04 | | | | | | | | | | | | | |B04=
<center>'''Workups'''</center>
<center>'''Workups'''</center>
----
----
Line 123: Line 121:
❑ Lactate<br>
❑ Lactate<br>
❑ ECG<br>
❑ ECG<br>
❑ CXR<br>  
❑ CXR<br>
❑ Echocardiography<br>
❑ Echocardiography<br>
❑ Central venous catheter<br>
❑ Central venous catheter
❑ Pulmonary artery catheter}}
❑ Pulmonary artery catheter
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: left; height: 260px;              | | | | | | | | | | | | | B05 | | | | | | | | | | | | | |B05=
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 20px; padding: 5px; text-align: left; height: 230px;              | | | | | | | | | | | | | B05 | | | | | | | | | | | | | |B05=
<center>'''Immediate Goals'''<ref name="Dellinger-2013">{{Cite journal  | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. | journal = Crit Care Med | volume = 41 | issue = 2 | pages = 580-637 | month = Feb | year = 2013 | doi = 10.1097/CCM.0b013e31827e83af | PMID = 23353941 }}</ref></center>
<center>'''Immediate Goals'''<ref name="Dellinger-2013">{{Cite journal  | last1 = Dellinger | first1 = RP. | last2 = Levy | first2 = MM. | last3 = Rhodes | first3 = A. | last4 = Annane | first4 = D. | last5 = Gerlach | first5 = H. | last6 = Opal | first6 = SM. | last7 = Sevransky | first7 = JE. | last8 = Sprung | first8 = CL. | last9 = Douglas | first9 = IS. | title = Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. | journal = Crit Care Med | volume = 41 | issue = 2 | pages = 580-637 | month = Feb | year = 2013 | doi = 10.1097/CCM.0b013e31827e83af | PMID = 23353941 }}</ref></center>
----
----
Line 141: Line 140:
❑ Lactate <2.2 mM/L<br>
❑ Lactate <2.2 mM/L<br>
❑ Urine output >0.5 mL/kg/h}}
❑ Urine output >0.5 mL/kg/h}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left;                            | | | | | | | | | | | | | |!| | | | | | | | | | | | | | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: center; height: 40px;            | | | | | | | | | | | | | B06 | | | | | | | | | | | | | |B06=
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 20px; padding: 5px; text-align: center; height: 40px;            | | | | | | | | | | | | | B06 | | | | | | | | | | | | | |B06=
'''Classify and Treat Accodringly'''}}
'''Classify Shock<br>and Treat Accordingly'''}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 10px; padding: 5px; text-align: left;                            | |,|-|-|-|-|-|v|-|-|-|-|-|^|-|-|-|-|-|v|-|-|-|-|-|.| | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 10px; padding: 5px; text-align: left;                            | |,|-|-|-|-|-|v|-|-|-|-|-|^|-|-|-|-|-|v|-|-|-|-|-|.| | |}}
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; line-height: 20px; padding: 5px; text-align: center; height: 80px;             | B07 | | | | B08 | | | | | | | | | | B09 | | | | B10 | |B07='''[[Cardiogenic shock resident survival guide|Cardiogenic Shock]]'''
{{Family tree|border=2|boxstyle=background: #FA8072; color: #F8F8FF; font-size: 90%; line-height: 20px; padding: 5px; text-align: center; width: 75px; height: 75px;| B07 | | | | B08 | | | | | | | | | | B09 | | | | B10 | |B07='''[[Cardiogenic shock resident survival guide|Cardiogenic Shock]]'''
|B08='''[[Obstructive shock resident survival guide|Obstructive Shock]]'''
|B08='''[[Obstructive shock resident survival guide|Obstructive Shock]]'''
|B09='''[[Distributive shock resident survival guide|Distributive Shock]]'''
|B09='''[[Distributive shock resident survival guide|Distributive Shock]]'''
|B10='''[[Hypovolemic shock resident survival guide|Hypovolemic Shock]]'''}}
|B10='''[[Hypovolemic shock resident survival guide|Hypovolemic Shock]]'''}}
{{Family tree/end}}
{{Family tree/end}}
</span>
 
<sup>†</sup> <SMALL>''For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock.''</SMALL>
<sup>†</sup> <SMALL>''For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock.''</SMALL>
==Classification==


{| style="border: 2px solid #A8A8A8;" align="center"
{| style="border: 2px solid #A8A8A8;" align="center"

Revision as of 13:04, 8 April 2014

Shock
Resident Survival Guide
Overview
Causes
FIRE
Treatment
Do's
Don'ts

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ahmed Zaghw, MBChB. [2]

Synonyms and keywords: Circulatory shock

Overview

Shock is the syndrome of circulatory failure that results in inadequate cellular oxygen utilization. The diagnosis of shock is based on clinical signs and biochemical abnormalities indicative of tissue hypoperfusion.[1]

Causes

Life Threatening Causes

Shock is a life-threatening condition and must be treated as such irrespective of the underlying cause.

Common Causes

  • Cardiogenic shock
  • Arrhythmic
  • Mechanical
  • Myocardial
  • Pharmacologic
  • Obstructive shock
  • Decreased cardiac compliance
  • Decreased ventricular preload
  • Increased ventricular afterload
  • Hypovolemic shock
  • Fluid depletion
  • Hemorrhage
  • Distributive shock

Click here for the complete list of causes.

FIRE: Focused Initial Rapid Evaluation

 
 
 
 
 
 
 
 
 
 
 
 
Symptoms & Signs


❑ Altered mental status
❑ Clammy skin ± cyanosis
❑ Hypotension (MAP <70 mmHg)
❑ Oliguria (urine output <0.5 mL/kg/h)

❑ Tachycardia (heart rate >100 bpm)
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Shock
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Ventilate—Infuse—Pump (VIP)[2][1]

❑ Intubation with mechanical ventilation
❑ Normal saline 0.5–1 L q10–15 min

❑ Norepinephrine 0.1–2.0 μg/kg/min
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Workups

❑ CBC/DC/SMA-7/PT/PTT
❑ Arterial blood gas
❑ Lactate
❑ ECG
❑ CXR
❑ Echocardiography
❑ Central venous catheter

❑ Pulmonary artery catheter
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Immediate Goals[3]

❑ MAP >65–70 mmHg
❑ CVP 8–12 mmHg
❑ PCWP 12–15 mmHg
❑ CI >2.1 L/min/m2
❑ SaO2 >90%–92%
❑ MVO2 >60%
❑ SCVO2 >70%
❑ Hemoglobin >7–9 g/dL
❑ Lactate <2.2 mM/L

❑ Urine output >0.5 mL/kg/h
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Classify Shock
and Treat Accordingly
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cardiogenic Shock
 
 
 
Obstructive Shock
 
 
 
 
 
 
 
 
 
Distributive Shock
 
 
 
Hypovolemic Shock
 

For septic and hypovolemic shock; consider normal saline 100—200 mL boluses for cardiogenic shock.

Classification of shock based on hemodynamic profiles and echocardiographic findings.[4][5][1]
Type of Shock CO SVR PCWP CVP SVO2 Echocardiographic Findings
Cardiogenic Acute Ventricular Septal Defect ↓↓ N — ↑ ↑↑ ↑ — ↑↑ Large ventricles with poor contractility
Acute Mitral Regurgitation ↓↓ ↑↑ ↑ — ↑↑
Myocardial Infarction ↓↓ ↑↑ ↑↑
Obstructive Pulmonary Embolism ↓↓ N — ↓ ↑↑ Dilated RV, small LV
Cardiac Tamponade ↓ — ↓↓ ↑↑ ↑↑ Pericardial effusion, small ventricles, dilated inferior vena cava
Distributive Septic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑ Normal cardiac chambers with preserved contractility
Anaphylactic Shock N — ↑↑ ↓ — ↓↓ N — ↓ N — ↓ ↑ — ↑↑
Hypovolemic Volume Depletion ↓↓ ↓↓ ↓↓ Small cardiac chambers with normal or high contractility

Do's

  • Resuscitation should be initiated while investigation of the cause is ongoing. Correct the cause of shock immediately once it is identified.

Don'ts

References

  1. 1.0 1.1 1.2 Vincent, JL.; De Backer, D. (2013). "Circulatory shock". N Engl J Med. 369 (18): 1726–34. doi:10.1056/NEJMra1208943. PMID 24171518. Unknown parameter |month= ignored (help)
  2. Weil, MH.; Shubin, H. (1969). "The VIP approach to the bedside management of shock". JAMA. 207 (2): 337–40. PMID 5818156. Unknown parameter |month= ignored (help)
  3. Dellinger, RP.; Levy, MM.; Rhodes, A.; Annane, D.; Gerlach, H.; Opal, SM.; Sevransky, JE.; Sprung, CL.; Douglas, IS. (2013). "Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012". Crit Care Med. 41 (2): 580–637. doi:10.1097/CCM.0b013e31827e83af. PMID 23353941. Unknown parameter |month= ignored (help)
  4. Parrillo, Joseph E.; Ayres, Stephen M. (1984). Major issues in critical care medicin. Baltimore: William Wilkins. ISBN 0-683-06754-0.
  5. Weil, Max Harry; Shubin, Herbert (1967). Diagnosis and Treatment of Shock. Williams & Wilkins. ISBN 1125885874.


Template:WikiDoc Sources